CervoMed(CRVO.US)

Last Updated 19:00:00 ET
longbridge loading

CervoMed climbs 4% during regular trading on patent approval, $10M offering

US Stock Market Update·
US
CRVO
+11.29%
US Stock Market Update·
US
CRVO
+11.29%

CervoMed Climbs 5% on USPTO Neflamapimod Patent Approval for DLB

US Stock Market Update·
US
CRVO
+11.29%
US Stock Market Update·
US
CRVO
+11.29%

CervoMed Surges 57% During Trading After US Patent Approval for DLB Drug

US Stock Market Update·
US
CRVO
+11.29%
US Stock Market Update·
US
CRVO
+11.29%

CervoMed 盘中急涨 现涨近 72%

US Stock Market Update·
US
CRVO
+11.29%
US Stock Market Update·
US
CRVO
+11.29%

CervoMed Soars 74% During Trading After US Patent Extension to 2042

US Stock Market Update·
US
CRVO
+11.29%
US Stock Market Update·
US
CRVO
+11.29%

12 Health Care Stocks Moving In Thursday's Pre-Market Session

benzinga_article·
US
LNAI
-5.50%
US
NVCR
-20.00%
US
SPRO
+8.06%
benzinga_article·
US
LNAI
-5.50%
US
NVCR
-20.00%
US
SPRO
+8.06%

CervoMed wins U.S. patent allowance for neflamapimod use in pure Lewy body dementia into 2042

PUBT·
US
CRVO
+11.29%
PUBT·
US
CRVO
+11.29%

CervoMed Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules | CRVO Stock News

StockTitan·
US
CRVO
+11.29%
StockTitan·
US
CRVO
+11.29%
© 2026 Longbridge｜Disclaimer